From: Abnormal arginine synthesis confers worse prognosis in patients with middle third gastric cancer
Parameter | Number of cases | Location | χ2 | p | |||
---|---|---|---|---|---|---|---|
Upper third | Middle third | Lower third | Mix | ||||
Age at diagnosis | |||||||
< 60 | 45 | 6 | 11 | 16 | 12 | 1.709 | 0.635 |
≥ 60 | 49 | 7 | 10 | 14 | 18 | ||
Gender | |||||||
Male | 68 | 11 | 13 | 24 | 20 | 3.629 | 0.304 |
Female | 26 | 2 | 8 | 6 | 10 | ||
Tumor size (cm) | |||||||
< 5 | 53 | 10 | 11 | 21 | 11 | 8.982 | 0.030 |
≥ 5 | 41 | 3 | 10 | 9 | 19 | ||
Histologic type | |||||||
Adenocarcinoma | 85 | 13 | 17 | 29 | 26 | 6.046 | 0.109 |
Signet ring cell carcinoma | 9 | 0 | 4 | 1 | 4 | ||
Degree of differentiation | |||||||
Medium-low/Medium/High | 42 | 4 | 9 | 11 | 18 | 3.434 | 0.329 |
Low | 52 | 9 | 12 | 19 | 12 | ||
Depth of invasion | |||||||
T1/T2 | 16 | 3 | 4 | 7 | 2 | 4.396 | 0.222 |
T3/T4 | 78 | 10 | 17 | 23 | 28 | ||
Lymph node status | |||||||
N0/N1/N2 | 59 | 11 | 13 | 19 | 16 | 0.352 | 0.354 |
N3 | 35 | 2 | 8 | 11 | 14 | ||
Distant metastasis | |||||||
M0 | 90 | 13 | 20 | 28 | 29 | 1.037 | 0.792 |
M1 | 4 | 0 | 1 | 2 | 1 | ||
TNM stage | |||||||
Stage I/II | 30 | 8 | 5 | 12 | 5 | 7.059 | 0.070 |
Stage III/IV | 64 | 5 | 16 | 18 | 15 |